EMR

Emerson Electric Co. Industrials - Electrical Equipment Investor Relations →

NO
23.2% ABOVE
↓ Approaching Was 27.4% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $104.03
14-Week RSI 44
Rel. Volume (14w) This week's trading vs. the 14-week average 1.0x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.85

Emerson Electric Co. (EMR) closed at $128.15 as of 2026-03-20, trading 23.2% above its 200-week moving average of $104.03. The stock is currently moving closer to the line, down from 27.4% last week. The 14-week RSI sits at 44, indicating neutral momentum.

Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.85 ratio) is neutral — neither side is clearly dominating.

Over the past 2759 weeks of data, EMR has crossed below its 200-week moving average 37 times. On average, these episodes lasted 12 weeks. Historically, investors who bought EMR at the start of these episodes saw an average one-year return of +13.3%.

With a market cap of $72.1 billion, EMR is a large-cap stock. The company generates a free cash flow yield of 4.0%. Return on equity stands at 9.6%. The stock trades at 3.5x book value.

EMR is a Dividend Aristocrat, having increased its dividend for 25 or more consecutive years. The current yield is 173.00%. Management has been repurchasing shares, with a 4.8% reduction over three years.

Over the past 33.2 years, a hypothetical investment of $100 in EMR would have grown to $2250, compared to $2683 for the S&P 500. EMR has returned 9.8% annualized vs 10.4% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: EMR vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After EMR Crosses Below the Line?

Across 17 historical episodes, buying EMR when it crossed below its 200-week moving average produced an average return of +22.5% after 12 months (median +19.0%), compared to +11.2% for the S&P 500 over the same periods. 82% of those episodes were profitable after one year. After 24 months, the average return was +43.0% vs +26.6% for the index.

Each line shows $100 invested at the moment EMR crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

EMR has crossed below its 200-week MA 37 times with an average 1-year return of +13.3% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
May 1973Jul 1973108.9%-2.5%+16302.9%
Nov 1973Nov 197310.0%-39.0%+15514.6%
Dec 1973May 19757547.3%-35.5%+17716.7%
Jun 1975Jun 197512.6%+2.8%+17965.1%
Jul 1975Nov 19751713.0%+3.5%+17785.1%
Dec 1975Jan 197669.5%+4.2%+18996.4%
Mar 1976Apr 197651.3%-3.6%+17684.5%
May 1976Jun 197610.1%-5.9%+17711.9%
Aug 1976Sep 197633.7%-2.6%+18464.5%
Oct 1976Jun 19773410.1%-1.0%+18629.6%
Jul 1977Jul 197711.1%+11.1%+18823.8%
Aug 1977Aug 197731.9%+18.5%+18964.5%
Oct 1977Nov 197710.2%+7.8%+19035.1%
Jan 1978Apr 1978118.0%+18.4%+19232.7%
Feb 1979Feb 197910.0%+7.3%+18074.6%
Apr 1979Apr 197910.4%+0.2%+18143.4%
Jul 1979Jul 197910.4%+23.4%+18084.4%
Oct 1979Dec 197971.7%+14.4%+18187.9%
Mar 1980Apr 198085.3%+38.0%+18257.2%
Sep 1990Oct 199010.0%+55.9%+3990.4%
Jan 2000Apr 2000923.7%+43.8%+908.1%
Apr 2000Apr 200013.1%+27.1%+885.1%
Jul 2001Feb 20023321.8%-6.9%+793.2%
Mar 2002May 200276.2%-16.8%+758.9%
Jun 2002Aug 20036322.1%-1.3%+760.0%
Sep 2003Oct 200321.1%+20.1%+787.4%
Sep 2008Nov 20095738.1%+4.3%+446.5%
Aug 2011Aug 201113.2%+26.1%+347.7%
Sep 2011Oct 201145.6%+18.4%+338.0%
Jul 2015Mar 20163620.3%+3.2%+216.3%
Apr 2016Apr 201610.1%+14.2%+207.0%
May 2016Jul 2016105.8%+14.5%+210.1%
Aug 2016Nov 2016149.0%+17.6%+204.6%
Aug 2019Aug 201921.6%+24.3%+157.9%
Mar 2020May 20201127.7%+88.7%+190.3%
Jun 2020Jul 202032.1%+64.4%+141.7%
Sep 2022Oct 202221.7%+34.6%+85.9%
Average12+13.3%

Frequently Asked Questions

Is EMR below its 200-week moving average?

No. Emerson Electric Co. (EMR) is currently 23.2% above its 200-week moving average of $104.03. It would need to fall to $104.03 to cross below the line.

What is EMR's 200-week moving average price?

Emerson Electric Co.'s 200-week moving average is $104.03 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when EMR drops below its 200-week moving average?

EMR has crossed below its 200-week moving average 37 times in our data. On average, buying at that moment produced a one-year return of +13.3%. These dips have historically been decent entry points. These episodes lasted 12 weeks on average.

Is EMR a good value right now?

Here's what our data says about EMR as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 44. Free cash flow yield is 4.0%. Return on equity is 9.6%. Price-to-book is 3.5x. This is not a buy or sell recommendation — always do your own research.

How does EMR compare to the S&P 500?

Over the past 33.2 years, $100 invested in EMR would have grown to $2250, compared to $2683 for the S&P 500. That's 9.8% annualized vs 10.4% for the index. EMR has underperformed the broader market over this period.

Does EMR pay a dividend?

Yes. Emerson Electric Co. currently pays a dividend yield of 173.00%. It is also a Dividend Aristocrat, meaning it has raised its dividend for 25 or more consecutive years.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-03-20